Rydex Biotechnology Inv
Limited financial coverage for RYOIX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
- IPO
- 1998
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on RYOIX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $96.49M
- Div Yield
- 10.29%
- 52W High
- $98.74
- 52W Low
- $72.00
- 50D MA
- $93.49
- 200D MA
- $82.82
- Beta
- 0.68
- RSI (14)
- 41
- Avg Volume
- 0
No earnings-call transcripts are available for RYOIX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 1.06M
- Float Shares
- 0
Our RYOIX coverage
Recent articles, reports, and earnings notes.
No research on RYOIX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RYOIX report →